Litigation Details for Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-02-22 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 10,004,729; 7,771,707; 8,449,909; 8,557,291; 8,758,813; 8,840,928; 9,044,398; 9,248,195; 9,592,200; 9,682,075; 9,737,530; 9,763,883; 9,968,598 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-09-11 | 107 | Report and Recommendations | #39;"883 patent"), 9,968,598 (the '"598 patent") and 10,004,729 (the '"…infringement of 13 patents: United States Patent Nos. 7,771,707 (the "'707 patent"), 8,449,…quot;729 patent" and collectively with the other patents, "the asserted patents"). Presently…,909 (the "'909 patent"), 8,557,291 (the "'291 patent"), 8,758,813 (the &… "'813 patent"), 8,840,928 (the '"928 patent"), 9,044,398 (the '" | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
